SCHOENBERG MARK (Chief Medical Officer) sold 4.8% of their position (7.37K shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $145.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 2/4/2026ACC: 0001437749-26-003040
Officer· Chief Medical Officer
Since Jan 2019
-7.37K
Net shares
Net seller
$145.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
7.37K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
−1.84K
Price / share
$19.69
Trade value
$36.31K
% of position
1.2%
2/3/2026
152.36K→150.51K
Ordinary Shares
Direct
Shares
−1.84K
Price / share
$19.69
Trade value
$36.29K
% of position
1.2%
2/3/2026
150.51K→148.67K
Ordinary Shares
Direct
Shares
−3.69K
Price / share
$19.69
Trade value
$72.58K
% of position
2.5%
2/3/2026
148.67K→144.99K
Total
Net shares
−7.37K
Net value
-$145.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/3/2026 | S · Sale | −1.84K | $19.69 | $36.31K | 1.2% | 152.36K | 150.51K |
| Ordinary Shares Direct | 2/3/2026 | S · Sale | −1.84K | $19.69 | $36.29K | 1.2% | 150.51K | 148.67K |
| Ordinary Shares Direct | 2/3/2026 | S · Sale | −3.69K | $19.69 | $72.58K | 2.5% | 148.67K | 144.99K |
| Total | −7.37K | -$145.17K | ||||||
Derivative Transactions0
No derivative transactions reported